Literature DB >> 31121284

Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease.

Lucian Del Fabbro1, André Rossito Goes1, Cristiano Ricardo Jesse1, Marcelo Gomes de Gomes2, Leandro Cattelan Souza1, Fernando V Lobo Ladd3, Aliny A B Lobo Ladd4, Ricardo Vinicius Nunes Arantes5, Astor Reis Simionato6, Mauro Schneider Oliveira7, Ana Flavia Furian8, Silvana Peterini Boeira1.   

Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disorder that severely affects quality of life of patients and their families. The flavonoid chrysin (5,7-dihydroxylflavone) is a naturally occurring flavone with several pharmacological activities, including anti-inflammatory and anti-oxidative. We investigated the effects of a 28-day chrysin treatment (10 mg/kg/day, i.g.) on a model of PD induced by 6-OHDA in aged (20-month old) mice. We found a protective effect of chrysin on behavioral and cognitive alterations (rotational behavior, passive avoidance and Barnes maze tests), nitric oxide synthesis (NOx), lipid peroxidation (HNE), glutathione levels (GSH), reactive species levels (RS), neuroinflammation (interleukin-1 beta - IL-1β and tumor necrosis factor alpha - TNF-α), Na+, K+-ATPase and nicotinamide adenine dinucleotide phosphate oxidase activity (NADPH oxidase) activities. In addition, chrysin protected against changes in striatal dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels. In conclusion, chrysin improved several behavioral, cognitive and neurochemical parameters in a relevant preclinical model of PD in aged mice.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavior; Dopaminergic neurons; Neuroinflammation; Old-mice; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31121284     DOI: 10.1016/j.neulet.2019.05.036

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols.

Authors:  Arslan Iftikhar; Rimsha Nausheen; Humaira Muzaffar; Muhammad Ahsan Naeem; Muhammad Farooq; Mohsin Khurshid; Ahmad Almatroudi; Faris Alrumaihi; Khaled S Allemailem; Haseeb Anwar
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

2.  Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.

Authors:  Michelle S Antunes; Fernando Vagner Lobo Ladd; Aliny Antunes Barbosa Lobo Ladd; Amanda Lopez Moreira; Silvana Peterini Boeira; Leandro Cattelan Souza
Journal:  Metab Brain Dis       Date:  2020-10-15       Impact factor: 3.584

Review 3.  Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders.

Authors:  Awanish Mishra; Pragya Shakti Mishra; Ritam Bandopadhyay; Navneet Khurana; Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Molecules       Date:  2021-10-26       Impact factor: 4.411

4.  Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.

Authors:  Takayuki Kobayashi; Jun-Dal Kim; Akira Naito; Asako Yanagisawa; Takayuki Jujo-Sanada; Yoshitoshi Kasuya; Yoshimi Nakagawa; Seiichiro Sakao; Koichiro Tatsumi; Takuji Suzuki
Journal:  Int J Mol Med       Date:  2022-03-22       Impact factor: 4.101

Review 5.  Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives.

Authors:  Rengasamy Balakrishnan; Shofiul Azam; Duk-Yeon Cho; In Su-Kim; Dong-Kug Choi
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

6.  Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease.

Authors:  Carmen Costas; Lilian R F Faro
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.